Trial Profile
Investigation of von Willebrand factor in the prevention of bleeding episodes in patients with von Willebrand disease.
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Apr 2014
Price :
$35
*
At a glance
- Drugs Vonicog alfa (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- 28 Apr 2014 Study title is not official.
- 28 Apr 2014 New trial record